Genmab — Juli 2019
-
Der er da guldkorn indimellem..:-)
-
-
Alene den flotte udsigt ville da gøre mig glad:-D
-
Det er da et fedt kontor, nohope.
-
Der kommer regn fredag og lørdag.
-
Måske ikke 30 mm...men mindre hjælper vel også..:-D
-
CEO of Novartis, said in earnings quote:
"Novartis delivered an exceptional first half [blablabla]. We continue to progress our breakthrough medicines pipeline, with the launches of Zolgensma and Piqray, and are on track for the upcoming pivotal trial results of Entresto in preserved ejection fraction heart failure, ofatumumab in multiple sclerosis, and fevipiprant in asthma." -
Fra Novartis' CONDENSED INTERIM FINANCIAL REPORT Q2, s. 18 https://www.novartis.com/sites/www.novartis.com/files/2019-07-interim-financial-report-en.pdf
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind